Download
women s health initiative trial of estrogen plus progestin n.
Skip this Video
Loading SlideShow in 5 Seconds..
Women’s Health Initiative: Trial of Estrogen plus Progestin PowerPoint Presentation
Download Presentation
Women’s Health Initiative: Trial of Estrogen plus Progestin

Women’s Health Initiative: Trial of Estrogen plus Progestin

170 Views Download Presentation
Download Presentation

Women’s Health Initiative: Trial of Estrogen plus Progestin

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Women’s Health Initiative: Trial of Estrogen plus Progestin • 16,608 women randomized • Conjugated equine estrogens 0.625 mg/d + medroxyprogesterone acetate 2.5 mg/d vs. placebo • Primary outcome: nonfatal MI or CHD death • Primary adverse outcome: breast cancer • Stopped early (mean follow-up 5.2 years) because health risks exceeded benefits Writing Group for the WHI Investigators. JAMA 2002;288:321-333.

  2. Risks and Benefits of Estrogen/Progestin on Clinical Outcomes: Women’s Health Initiative *1st event: CHD; stroke; pulmonary embolism; breast, endometrial, or colorectal cancer; hip fracture, or death due to other causes Writing Group for the WHI Investigators. JAMA 2002;288:321-333.

  3. Absolute Excess Risks and Absolute Risk Reductions per 10,000 Person-Years: Women’s Health Initiative Writing Group for the WHI Investigators. JAMA 2002;288:321-333.